Intuitive Surgical loses 5% despite strong Q4 earnings ðŸšĐSlowing growth pace?

23:45 24 āļĄāļāļĢāļēāļ„āļĄ 2025

Shares of Intuitive Surgical (ISRG.US) are losing 5% after its Q4 2024 financial results, even though the company beat forecasts on revenue and earnings per share. Part of the reason for the decline was that the company expects 2025 operations to grow 13%-16% y/y, so below the 17% growth rate in 2024. Analysts had expected growth of 17.1% in 2025. The company installed as many as 174 da Vinci 5 robots in the US in Q4, up from 110 in Q3 2024, but pricing strategies in the Chinese market yielded weaker-than-expected results.

Q4 2024 financial results

  • Intuitive Surgical achieved adjusted earnings per share of $2.21, beating forecasts of $1.79 by more than 22%
  • Revenue was $2.41 billion, beating expectations of $2.25 billion. Year-on-year sales growth was 25%.
  • The company installed 493 new surgical systems, including 174 da Vinci 5; about 66% sales result above expectations.
  • The number of procedures performed with Intuitive Surgical's systems increased 18%, driving higher sales of disposable surgical instruments and accessories.
  • Instrument sales increased 23% to reach $1.41 billion in Q4, which exceeded forecasts of $1.37 billion.
  • Intuitive Surgical had about 34% penetration of the robotic surgery market at the end of 2024, which could give it room in the long term to double its target market in the future (22 million surgeries per year)
  • Intuitive's current scale is 8 million surgeries per year, not including the additional 700,000 per year associated with the lung biopsy robot, Ion.

Oppenheimer with tentative evaluation of Intuitive

Intuitive Surgical has signed a significant distribution agreement worth 290 million euros, to be finalized by 2026. The agreement will give the company a direct presence in Italy, Spain and Portugal. The company has also received approval for thoracic and colorectal indications for the SP system, which will likely help commercialize the product. Nonetheless, analysts at Oppenheimer pointed to several concerns around valuation and business:

āđ€āļĢāļīāđˆāļĄāđ€āļ—āļĢāļ”āļ—āļąāļ™āļ—āļĩāļ§āļąāļ™āļ™āļĩāđ‰ āļŦāļĢāļ·āļ­ āļĨāļ­āļ‡āđƒāļŠāđ‰āļšāļąāļāļŠāļĩāļ—āļ”āļĨāļ­āļ‡āđāļšāļšāđ„āļĢāđ‰āļ„āļ§āļēāļĄāđ€āļŠāļĩāđˆāļĒāļ‡

āđ€āļ›āļīāļ”āļšāļąāļāļŠāļĩ āļĨāļ­āļ‡āļšāļąāļāļŠāļĩāđ€āļ”āđ‚āļĄāđˆ āļ”āļēāļ§āļ™āđŒāđ‚āļŦāļĨāļ”āđāļ­āļ›āļĄāļ·āļ­āļ–āļ·āļ­ āļ”āļēāļ§āļ™āđŒāđ‚āļŦāļĨāļ”āđāļ­āļ›āļĄāļ·āļ­āļ–āļ·āļ­
  • They estimate that the U.S. market for Intuitive Surgical products appears to be reaching saturation levels. The added value of the new dV5 system, priced as much as 30% above the price of the previous Xi model, remains uncertain.
  • On the other hand, Truist Securities, Deutsche Bank, BTIG and Raymond James have raised their target prices for ISRG shares; Bernstein reaffirmed its Outperform rating and set a target price of $700. 
  • The company's gross margin was 69.5% and operating margin was 38.4%. Strong margins on sales of the new Da Vinci 5 robots contributed to the impressive quarterly results.
  • Analysts predict that the company's financial performance will improve throughout the year. The growth prospects are underpinned by five breakthrough product cycles that Bernstein's analysis says will accelerate the company's growth in the near future. In an optimistic scenario, analysts predict that Intuitive Surgical's EPS could reach $11.50 by 2026. Revenue growth, solid financial health and the expected widespread introduction of the new dV5 system are key factors supporting optimism. 

Intuitive Surgical shares (D1)

The company's shares are retreating nearly 5% today, however, giving back relatively little of the recent euphoric gains. Investors may be noting that the company's valuation has become challenging due to the great health of the business, and any even 'minor stumble' could be costly for new shareholders. The price/earnings ratio is nearly 4 times the average of S&P 500 companies, and currently stands at about 93 times Intuitive Surgical's annual earnings.

Source: xStation5

āļŦāļļāđ‰āļ™:
āļāļĨāļąāļšāđ„āļ›

āļ‚āđˆāļēāļ§āđƒāļ™āļ•āļĨāļēāļ”āļāļēāļĢāđ€āļ‡āļīāļ™

30.06.2025
01:16

āļ‚āđˆāļēāļ§āđ€āļ”āđˆāļ™āļ§āļąāļ™āļ™āļĩāđ‰: āļ”āļ­āļĨāļĨāļēāļĢāđŒāļ­āđˆāļ­āļ™āļ„āđˆāļē āļ‚āļ“āļ°āļ—āļĩāđˆāļ”āļąāļŠāļ™āļĩāļŦāļļāđ‰āļ™āļŠāļŦāļĢāļąāļāļŊ āļžāļļāđˆāļ‡āļ—āļģāļˆāļļāļ”āļŠāļđāļ‡āļŠāļļāļ”āđƒāļŦāļĄāđˆāļ­āļĩāļāļ„āļĢāļąāđ‰āļ‡ (30.06.2025)

āļ”āļąāļŠāļ™āļĩāļŦāļļāđ‰āļ™āļŠāļŦāļĢāļąāļāļŊ āļ›āļīāļ”āđ„āļ•āļĢāļĄāļēāļŠ 2 āļ›āļĩ 2025 āļ—āļĩāđˆāļĢāļ°āļ”āļąāļšāļŠāļđāļ‡āļŠāļļāļ”āđ€āļ›āđ‡āļ™āļ›āļĢāļ°āļ§āļąāļ•āļīāļāļēāļĢāļ“āđŒ āļ—āđˆāļēāļĄāļāļĨāļēāļ‡āļ—āđˆāļēāļ—āļĩāļ‚āļ­āļ‡āļ˜āļ™āļēāļ„āļēāļĢāļāļĨāļēāļ‡āļŠāļŦāļĢāļąāļāļŊ (Fed) āļ—āļĩāđˆāđ€āļĢāļīāđˆāļĄāļ­āđˆāļ­āļ™āļĨāļ‡ āđāļĨāļ°āļ„āļ§āļēāļĄāļ„āļēāļ”āļŦāļ§āļąāļ‡āđ€āļāļĩāđˆāļĒāļ§āļāļąāļšāļ‚āđ‰āļ­āļ•āļāļĨāļ‡āļ—āļēāļ‡āļāļēāļĢāļ„āđ‰āļēāļĢāļ°āļŦāļ§āđˆāļēāļ‡āļŠāļŦāļĢāļąāļāļŊ...

22:45

EURUSD āļ—āļ°āļĨāļļāļĢāļ°āļ”āļąāļš 1.1750 āļŦāļĨāļąāļ‡ Fed āļŠāđˆāļ‡āļŠāļąāļāļāļēāļ“āļœāđˆāļ­āļ™āļ„āļĨāļēāļĒ ðŸ•Šïļ

EUR/USD āđ€āļ”āļīāļ™āļŦāļ™āđ‰āļēāļ—āļ°āļĨāļļ 1.1750 āļ•āđˆāļ­āđ€āļ™āļ·āđˆāļ­āļ‡ āļŦāļĨāļąāļ‡āļ›āļĢāļ°āļ˜āļēāļ™ Fed āļŠāļēāļ‚āļēāđāļ­āļ•āđāļĨāļ™āļ•āļēāļŠāđˆāļ‡āļŠāļąāļāļāļēāļ“āļœāđˆāļ­āļ™āļ„āļĨāļēāļĒ āļ„āļđāđˆāđ€āļ‡āļīāļ™ EUR/USD āļĒāļąāļ‡āļ„āļ‡āļžāļļāđˆāļ‡āļ‚āļķāđ‰āļ™āđ€āļŦāļ™āļ·āļ­āļĢāļ°āļ”āļąāļš 1.1750 āļŦāļĨāļąāļ‡āļˆāļēāļ Raphael Bostic...

21:43

āļ‚āđˆāļēāļ§āđ€āļ”āđˆāļ™: āļāļīāļˆāļāļĢāļĢāļĄāļ āļēāļ„āļāļēāļĢāļœāļĨāļīāļ•āļ‚āļ­āļ‡ Fed āļŠāļēāļ‚āļēāļ”āļąāļĨāļĨāļąāļŠāļ•āđˆāļģāļāļ§āđˆāļēāļ—āļĩāđˆāļ„āļēāļ”āļāļēāļĢāļ“āđŒāđ„āļ§āđ‰

15:30 BST, āļŠāļŦāļĢāļąāļāļ­āđ€āļĄāļĢāļīāļāļē - āļ”āļąāļŠāļ™āļĩāļāļīāļˆāļāļĢāļĢāļĄāļ āļēāļ„āļāļēāļĢāļœāļĨāļīāļ•āļ‚āļ­āļ‡ Fed āļŠāļēāļ‚āļēāļ”āļąāļĨāļĨāļąāļŠ āļ›āļĢāļ°āļˆāļģāđ€āļ”āļ·āļ­āļ™āļĄāļīāļ–āļļāļ™āļēāļĒāļ™ āļ•āļąāļ§āđ€āļĨāļ‚āļˆāļĢāļīāļ‡: -12.7 āļ„āļēāļ”āļāļēāļĢāļ“āđŒ: -12 āļāđˆāļ­āļ™āļŦāļ™āđ‰āļē:...

āđ€āļ‚āđ‰āļēāļŠāļđāđˆāļ•āļĨāļēāļ”āļžāļĢāđ‰āļ­āļĄāļĨāļđāļāļ„āđ‰āļēāļ‚āļ­āļ‡ XTB Group āļāļ§āđˆāļē 1 600 000 āļĢāļēāļĒ

āļœāļĨāļīāļ•āļ āļąāļ“āļ‘āđŒāļ—āļēāļ‡āļāļēāļĢāđ€āļ‡āļīāļ™āļ—āļĩāđˆāđ€āļĢāļēāđƒāļŦāđ‰āļšāļĢāļīāļāļēāļĢāļĄāļĩāļ„āļ§āļēāļĄāđ€āļŠāļĩāđˆāļĒāļ‡ āđ€āļĻāļĐāļŦāļļāđ‰āļ™ (Fractional Shares) āđ€āļ›āđ‡āļ™āļœāļĨāļīāļ•āļ āļąāļ“āļ‘āđŒāļ—āļĩāđˆāđƒāļŦāđ‰āļšāļĢāļīāļāļēāļĢāļˆāļēāļ XTB āđāļŠāļ”āļ‡āļ–āļķāļ‡āļāļēāļĢāđ€āļ›āđ‡āļ™āđ€āļˆāđ‰āļēāļ‚āļ­āļ‡āļŦāļļāđ‰āļ™āļšāļēāļ‡āļŠāđˆāļ§āļ™āļŦāļĢāļ·āļ­ ETF āđ€āļĻāļĐāļŦāļļāđ‰āļ™āđ„āļĄāđˆāđƒāļŠāđˆāļœāļĨāļīāļ•āļ āļąāļ“āļ‘āđŒāļ—āļēāļ‡āļāļēāļĢāđ€āļ‡āļīāļ™āļ­āļīāļŠāļĢāļ° āļŠāļīāļ—āļ˜āļīāļ‚āļ­āļ‡āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ­āļēāļˆāļ–āļđāļāļˆāļģāļāļąāļ”
āļ„āļ§āļēāļĄāļŠāļđāļāđ€āļŠāļĩāļĒāļŠāļēāļĄāļēāļĢāļ–āđ€āļāļīāļ™āļāļ§āđˆāļēāđ€āļ‡āļīāļ™āļ—āļĩāđˆāļāļēāļ